Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 24,696 | 20,510 | 14,502 | 10,869 | 10,338 |
| Operating Income | -24,696 | -20,510 | -14,502 | -10,869 | -10,338 |
| Other Income | -19,490 | 97,481 | -30,405 | -12,762 | -19,761 |
| Pre-tax Income | -44,186 | 76,971 | -44,907 | -23,631 | -30,099 |
| Net Income Continuous | -44,617 | 76,971 | -44,907 | -23,631 | -30,099 |
| Net Income | $-44,617 | $76,971 | $-44,907 | $-23,631 | $-30,099 |
| EPS Basic Total Ops | -0.14 | 1.05 | -0.92 | -0.65 | 0.08 |
| EPS Basic Continuous Ops | -0.38 | 1.48 | -1.06 | -0.79 | -0.91 |
| EPS Diluted Total Ops | 1.19 | -0.28 | -0.92 | -0.65 | 0.08 |
| EPS Diluted Continuous Ops | -0.28 | 1.39 | -1.06 | -0.79 | -0.91 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.32 | -0.32 | -0.34 | N/A |
| EBITDA(a) | $-24,696 | $-20,510 | $-14,502 | $-10,869 | $-10,244 |